Phreesia, Inc. (NYSE:PHR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have received a consensus rating of “Moderate Buy” from the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $29.42.

A number of equities analysts have issued reports on PHR shares. Truist Financial lifted their price target on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a research report on Thursday, September 5th. KeyCorp dropped their price objective on Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. Finally, JPMorgan Chase & Co. upped their target price on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday.

Phreesia Trading Up 1.9 %

NYSE:PHR opened at $23.76 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. Phreesia has a one year low of $12.05 and a one year high of $29.16. The company has a market cap of $1.36 billion, a PE ratio of -10.95 and a beta of 0.93. The firm has a 50-day moving average of $23.63 and a 200-day moving average of $22.75.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 2,622 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $60,961.50. Following the transaction, the general counsel now directly owns 123,075 shares in the company, valued at $2,861,493.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, General Counsel Allison C. Hoffman sold 2,622 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total transaction of $60,961.50. Following the completion of the sale, the general counsel now owns 123,075 shares in the company, valued at approximately $2,861,493.75. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Evan Roberts sold 3,148 shares of Phreesia stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $73,191.00. Following the completion of the sale, the chief operating officer now directly owns 755,719 shares in the company, valued at approximately $17,570,466.75. The disclosure for this sale can be found here. Insiders have sold 46,364 shares of company stock worth $1,132,627 in the last ninety days. Company insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. nVerses Capital LLC increased its holdings in Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after acquiring an additional 1,300 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Phreesia by 5,462.3% in the fourth quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after purchasing an additional 3,769 shares in the last quarter. EntryPoint Capital LLC bought a new stake in shares of Phreesia in the first quarter valued at approximately $169,000. Quadrature Capital Ltd purchased a new stake in shares of Phreesia during the 1st quarter valued at approximately $202,000. Finally, Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia during the 2nd quarter valued at approximately $202,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.